Finch Announces Reverse Stock Split of Common Stock
June 09, 2023 07:00 ET
|
Finch Therapeutics Group, Inc.
BOSTON, June 09, 2023 (GLOBE NEWSWIRE) -- Finch Therapeutics Group, Inc. (“Finch”, “Finch Therapeutics” or the “Company”) (Nasdaq: FNCH), a microbiome technology company with a portfolio of...
Global Human Microbiome Market Report to 2029: Rising Awareness About Importance of Human Microbiome Drives Growth
June 06, 2023 09:53 ET
|
Research and Markets
Dublin, June 06, 2023 (GLOBE NEWSWIRE) -- The "Global Human Microbiome Market by Product (Drugs, Probiotics, Prebiotics), Application (Therapeutic, Diagnostics), Disease (Cancer, Gastrointestinal,...
Global Microbiome Sequencing Services Market Report 2023: Increasing Demand for Metagenomic Sequencing Drives Growth
May 29, 2023 07:53 ET
|
Research and Markets
Dublin, May 29, 2023 (GLOBE NEWSWIRE) -- The "Global Microbiome Sequencing Services Market by Service (Sample Preparation, Sequencing, Library Preparation), Type (Amplicon Sequencing, Whole Genome...
Finch Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Updates
May 10, 2023 07:00 ET
|
Finch Therapeutics Group, Inc.
SOMERVILLE, Mass., May 10, 2023 (GLOBE NEWSWIRE) -- Finch Therapeutics Group, Inc. (“Finch”, “Finch Therapeutics” or the “Company”) (Nasdaq: FNCH), a microbiome technology company with a portfolio...
Live Biotherapeutic Products And Microbiome CDMO Global Market Report 2023: Sector to Reach $358.07 Million by 2030 at a 41.3% CAGR
May 09, 2023 07:58 ET
|
Research and Markets
Dublin, May 09, 2023 (GLOBE NEWSWIRE) -- The "Live Biotherapeutic Products And Microbiome CDMO Market Size, Share & Trends Analysis Report By Application (C.difficle, Crohns Disease, IBS,...
Microbiome Sequencing Services Global Market Report 2023: Increased Genomic Research and Expanded Uses for Microbiome Sequencing Drives Growth
May 09, 2023 05:18 ET
|
Research and Markets
Dublin, May 09, 2023 (GLOBE NEWSWIRE) -- The "Microbiome Sequencing Services Market Size, Share & Trends Analysis Report By Technology (Sequencing By Synthesis, Sequencing By Ligation, Sanger...
Global Microbiome Competitive Landscape Report 2023: Comprehensive Insights on 130+ Companies and 180+ Drugs
April 28, 2023 09:53 ET
|
Research and Markets
Dublin, April 28, 2023 (GLOBE NEWSWIRE) -- The "Microbiome - Competitive landscape, 2023" report has been added to ResearchAndMarkets.com's offering.This "Microbiome- Competitive landscape, 2023"...
Finch Therapeutics Announces Executive Leadership Transitions
April 25, 2023 16:05 ET
|
Finch Therapeutics Group, Inc.
Matthew P. Blischak, an experienced life sciences executive and intellectual property counsel, appointed as Chief Executive Officer effective May 16, 2023; Mark Smith, PhD, to complete his time as CEO...
Pan-Biome Pharmaceuticals, a startup focused on age-related diseases and increasing human healthspan, reports positive results in a preclinical trial of colitis
April 25, 2023 10:00 ET
|
Pan-Biome Pharmaceuticals, Inc
VANCOUVER, British Columbia, April 25, 2023 (GLOBE NEWSWIRE) -- Pan-Biome Pharmaceuticals, Inc, a Vancouver based preclinical biopharmaceutical company focused on age-related diseases and extending...
Finch Therapeutics Announces Clinical Collaboration in Ulcerative Colitis with Brigham and Women’s Hospital and Updates to University of Minnesota License Agreement
April 18, 2023 16:01 ET
|
Finch Therapeutics Group, Inc.
SOMERVILLE, Mass., April 18, 2023 (GLOBE NEWSWIRE) -- Finch Therapeutics Group, Inc. (“Finch”, “Finch Therapeutics” or the “Company”) (Nasdaq: FNCH), a microbiome technology company with a portfolio...